This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Sarepta Therapeutics said that a young man died after receiving Elevidys, its ge...
At a time when CRISPR companies have struggled, the Feng Zhang spinoff Arbor Bio...
PE firms are buying facilities that care for people with intellectual or develop...
Conservative stalwarts, Trump loyalists, friends of Bobby's — a look at eight ke...
Taxing employer-provided health care benefits for an extension of tax cuts could...
RFK Jr. has long called for a ban on drug ads entirely. That seems unlikely — bu...
The CDC is no longer processing transgender identity data, so researchers will h...
‘No one can fill that gap’: Why the head of the Wellcome Trust, the world’s four...
'A stopgap to the hospital closure crisis' has been used by only 38 facilities b...
The longtime director of the National Human Genome Research Institute is steppin...
The inquiry is the latest effort by the European Commission and European countri...
A Texas midwife has been arrested and accused of providing illegal abortions, Te...
Departures of key staff from the FDA could lead to delays in inspections and pro...
The agency noted that quantity restrictions can alter the competitive dynamics o...
The Trump administration has canceled funding for an ongoing 30-year, nationwide...
Breaking: The WHO issued its starkest warning yet on the consequences of the abr...
How a case involving Dana-Farber Cancer Institute illustrates the potential risk...
This week in health care business news: Dr. Oz will scrutinize Medicare Advantag...
Biotech news stories you need to read, brought to you by The Readout.
Want to stay on top of the science and politics driving biotech today? Sign up t...
In today's Pharmalittle roundup, we're reading about Medicare negotiations, U.K....
Moncef Slaoui, who ran the Operation Warp Speed Covid vaccine effort, is becomin...